96 related articles for article (PubMed ID: 22039016)
1. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
Tajima M; Wakita D; Satoh T; Kitamura H; Nishimura T
Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Accumulation of T Cytotoxic 1, T Cytotoxic 17, and T Cytotoxic 17/1 Cells in the Brain Contributes to Microglia-Mediated Chronic Neuroinflammation After Ischemic Stroke.
Shu L; Xu H; Ji J; Xu Y; Dong Z; Wu Y; Guo Y
Neuromolecular Med; 2024 Apr; 26(1):17. PubMed ID: 38684592
[TBL] [Abstract][Full Text] [Related]
3. Identification of the association of CD28
Han W; Li J; Zhou H; Qian J; Tong Z; Wang W; Zhong J; Xue T; Chen Q; Yao Y; Shao S
J Med Virol; 2020 Dec; 92(12):3534-3544. PubMed ID: 32568409
[TBL] [Abstract][Full Text] [Related]
4. The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity.
Kemp RA; Bäckström BT; Ronchese F
Immunology; 2005 Jul; 115(3):315-24. PubMed ID: 15946249
[TBL] [Abstract][Full Text] [Related]
5. Regulation of IFN-gamma signaling is essential for the cytotoxic activity of CD8(+) T cells.
Tau GZ; Cowan SN; Weisburg J; Braunstein NS; Rothman PB
J Immunol; 2001 Nov; 167(10):5574-82. PubMed ID: 11698428
[TBL] [Abstract][Full Text] [Related]
6. Exposure of Human CD8
Fox A; Harland KL; Kedzierska K; Kelso A
Front Immunol; 2018; 9():1141. PubMed ID: 29892290
[TBL] [Abstract][Full Text] [Related]
7. CD29 identifies IFN-γ-producing human CD8
Nicolet BP; Guislain A; van Alphen FPJ; Gomez-Eerland R; Schumacher TNM; van den Biggelaar M; Wolkers MC
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6686-6696. PubMed ID: 32161126
[TBL] [Abstract][Full Text] [Related]
8. Persistence of Th17/Tc17 cell expression upon smoking cessation in mice with cigarette smoke-induced emphysema.
Duan MC; Tang HJ; Zhong XN; Huang Y
Clin Dev Immunol; 2013; 2013():350727. PubMed ID: 24489575
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1.
Hasegawa K; Tagawa M; Takagi K; Tsukamoto H; Tomioka Y; Suzuki T; Nishioka Y; Ohrui T; Numasaki M
Cancer Gene Ther; 2016 Aug; 23(8):266-77. PubMed ID: 27561689
[TBL] [Abstract][Full Text] [Related]
10. Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients.
Kudryavtsev IV; Arsentieva NA; Korobova ZR; Isakov DV; Rubinstein AA; Batsunov OK; Khamitova IV; Kuznetsova RN; Savin TV; Akisheva TV; Stanevich OV; Lebedeva AA; Vorobyov EA; Vorobyova SV; Kulikov AN; Sharapova MA; Pevtsov DE; Totolian AA
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146713
[TBL] [Abstract][Full Text] [Related]
11. Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis.
Roberts SJ; Ng BY; Filler RB; Lewis J; Glusac EJ; Hayday AC; Tigelaar RE; Girardi M
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6770-5. PubMed ID: 17412837
[TBL] [Abstract][Full Text] [Related]
12. Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8
Lee GW; Kim YJ; Lee SW; Kim HO; Kim D; Kim J; Kim YM; Kang K; Rhee JH; Chung IJ; Bae WK; Oh IJ; Yang DH; Cho JH
Nat Commun; 2024 Apr; 15(1):2919. PubMed ID: 38575593
[TBL] [Abstract][Full Text] [Related]
13. Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis.
Greigert H; Ramon A; Genet C; Cladière C; Gerard C; Cuidad M; Corbera-Bellalta M; Alba-Rovira R; Arnould L; Creuzot-Garcher C; Martin L; Tarris G; Ghesquière T; Ouandji S; Audia S; Cid MC; Bonnotte B; Samson M
J Autoimmun; 2024 Jan; 142():103151. PubMed ID: 38039746
[TBL] [Abstract][Full Text] [Related]
14. Immune landscape of vulvar cancer patients treated with surgery and adjuvant radiotherapy revealed restricted T cell functionality and increased IL-17 expression associated with cancer relapse.
Gies S; Melchior P; Stroeder R; Tänzer T; Theobald L; Pohlers M; Glombitza B; Sester M; Solomayer EF; Walch-Rückheim B
Int J Cancer; 2024 Jan; 154(2):343-358. PubMed ID: 37786948
[TBL] [Abstract][Full Text] [Related]
15. Friend or Foe - Tc17 cell generation and current evidence for their importance in human disease.
Hipp AV; Bengsch B; Globig AM
Discov Immunol; 2023; 2(1):kyad010. PubMed ID: 38567057
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of
Erice PA; Huang X; Seasock MJ; Robertson MJ; Tung HY; Perez-Negron MA; Lotlikar SL; Corry DB; Kheradmand F; Rodriguez A
bioRxiv; 2024 Mar; ():. PubMed ID: 37905101
[TBL] [Abstract][Full Text] [Related]
17. The development of IL-17/IFN-γ-double producing CTLs from Tc17 cells is driven by epigenetic suppression of Socs3 gene promoter.
Satoh T; Tajima M; Wakita D; Kitamura H; Nishimura T
Eur J Immunol; 2012 Sep; 42(9):2329-42. PubMed ID: 22674086
[TBL] [Abstract][Full Text] [Related]
18. IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.
Huber M; Heink S; Pagenstecher A; Reinhard K; Ritter J; Visekruna A; Guralnik A; Bollig N; Jeltsch K; Heinemann C; Wittmann E; Buch T; Prazeres da Costa O; Brüstle A; Brenner D; Mak TW; Mittrücker HW; Tackenberg B; Kamradt T; Lohoff M
J Clin Invest; 2013 Jan; 123(1):247-60. PubMed ID: 23221338
[TBL] [Abstract][Full Text] [Related]
19. Tc17 Cells in Immunity and Systemic Autoimmunity.
Liang Y; Pan HF; Ye DQ
Int Rev Immunol; 2015; 34(4):318-31. PubMed ID: 25259411
[TBL] [Abstract][Full Text] [Related]
20. The inducible costimulator augments Tc17 cell responses to self and tumor tissue.
Nelson MH; Kundimi S; Bowers JS; Rogers CE; Huff LW; Schwartz KM; Thyagarajan K; Little EC; Mehrotra S; Cole DJ; Rubinstein MP; Paulos CM
J Immunol; 2015 Feb; 194(4):1737-47. PubMed ID: 25576595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
